C
Overview
Cedar Pine is a private investment firm near Chicago focused on strategic, long-term assets in healthcare, finance, and real estate. It uses decades of hands-on experience as operators and investors to identify and grow value in private markets. The firm does not act as an investment adviser and does not take outside capital, operating with its own capital and resources. Its goal is to build durable value over time through long-duration investments in its target sectors.
Work here?Claim your company
Simplify's Take
What believers are saying
- PDW closed a $110 million Series B in March 2026, expanding defense exposure.
- Stepful drew new secondary buying in April 2026, signaling investor demand.
- Wasabi and American Pain Consortium anchor software, storage, and healthcare diversification.
What critics are saying
- PDW's 2026 Pentagon diligence and conditional loan close create financing failure risk.
- Portfolio concentration in defense and healthcare ties Cedar Pine to regulation and procurement cycles.
- Failure at PDW or Stepful would damage reputation and slow future deal access.
What makes Cedar Pine unique
- Northbrook family office; no outside capital, so decisions stay concentrated and private.
- Targets profitable healthcare, finance, and defense assets, not broad venture exposure.
- Co-invests with Booz Allen Hamilton, Hanwha, and KKR on specialized deals.
Help us improve and share your feedback! Did you find this helpful?